SCHEMBL25518535

SCHEMBL25518535

CCC1(CC(C)C)CCN(C2CC3(CCN(C4CC5(CCNCC5)C4)CC3)C2)CC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25518430 0.82 HRH3 (0.32)
SCHEMBL19370306 0.75 CYP2D6 (0.39) CYP1A2TSHR
SCHEMBL22020558 0.75
SCHEMBL25513275 0.74 TSHR (0.36) TSHR
SCHEMBL22737182 0.74 CYP1A2 (0.33) CYP1A2TSHR
SCHEMBL24696697 0.72 HRH3 (0.30)
SCHEMBL24480862 0.72 HRH3 (0.33) CYP1A2TSHR
SCHEMBL24480646 0.72 CYP2D6 (0.35) CYP1A2TSHR
SCHEMBL27303962 0.72 L3MBTL3 (0.43) CYP1A2TSHR
SCHEMBL24185486 0.71 HRH3 (0.33) CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180427-A1 COMPOUND CAPABLE OF INHIBITING AND DEGRADING ANDROGEN RECEPTORS, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL USES THEREOF Sichuan Haisco Pharmaceutical Co., Ltd. (CN) 2023-05-17 EP disclosed